Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Boston Scientific buys Asthmatx from HBM BioVentures

Boston Scientific has acquired asthma medical device company Asthmatx from Swiss venture capital firm HBM Bioventures for $193.5m in cash, corresponding to almost twice the amount invested.

Additional payments of up to $250m will fall due when future sales milestones are reached, which would take the total return to a maximum of 4.5 times the investment made.

Asthmatx develops and manufactures catheter-based medical devices for patients with severe asthma. Asthmatx’s bronchial thermoplasty, delivered by the Alair System, is a novel device-based minimally invasive treatment option for patients with severe asthma.

The Alair System has been approved for use in the US by the FDA and has received a CE mark for use in the European Union.

HBM BioVentures is a major investor in Asthmatx and has played a significant role in the company’s growth since its initial investment in 2005. In 2007, Asthmatx received $50m from Olympus for the continued financing of its product development activities.